Phase II trial of AZP 531 in patients with type I diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
Price : $35 *
At a glance
- Drugs Livoletide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Dec 2017 According to an Alize Pharma media release, Alize Pharma SAS was acquired by Millendo Therapeutics and subsequently changed its named to Millendo Therapeutics SAS.
- 01 Oct 2014 New trial record
- 10 Sep 2014 This trial is expected to be initiated in the last quarter of 2014, according to an Alize Pharma media release.